Laboratory network supporting HIV treatment and clinical trials
AIDS Clinical Trial Group Laboratory Center
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-11237073
This program runs and coordinates labs that perform tests and develop assays to help HIV clinical trials for people living with HIV and related infections.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-11237073 on ClinicalTrials.gov |
What this research studies
As a person living with HIV, this program means there are quality-assured labs that process samples and run advanced tests to support clinical trials you might join. The network brings together domestic and international lab sites to standardize assays in virology, immunology, pharmacology, biomarkers, and genomics. It also develops new laboratory tests, trains lab staff, and provides ongoing quality control to keep trial results reliable. The work focuses on priorities like ART-free HIV remission, new antiviral therapies, tuberculosis co-infection, and HIV-related conditions including neurologic problems and hepatitis B.
Who could benefit from this research
Good fit: People living with HIV — including those with TB or hepatitis B co-infection — who are eligible to enroll at participating ACTG clinical sites would be the ideal candidates to benefit from this work.
Not a fit: People without HIV or those who do not attend or enroll in ACTG-affiliated clinical sites are unlikely to directly benefit from this program.
Why it matters
Potential benefit: Stronger, standardized lab testing could speed up safer and more effective HIV treatments and cures reaching patients.
How similar studies have performed: The ACTG has over 30 years of successful clinical trial and laboratory work that shaped current HIV treatment guidelines, so this builds on well-established efforts.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ALDROVANDI, GRACE M — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: ALDROVANDI, GRACE M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus